SCHEMBL10246043

SCHEMBL10246043

CN(CCCC(=O)O)S(=O)(=O)c1cccc(F)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.62
KMT2A Q03164 4/20 0.50
MEN1 O00255 3/20 0.50
SMN1; SMN2 Q16637 2/20 0.46
POLB P06746 1/20 0.46
HCRTR2 O43614 1/20 0.43
TDP1 Q9NUW8 1/20 0.42
HTR2A P28223 1/20 0.42
HTR2C P28335 1/20 0.42
PTGDR Q13258 2/20 0.42
PTGDR2 Q9Y5Y4 2/20 0.42
MAOA P21397 1/20 0.42
MAOB P27338 1/20 0.42
CASP3 P42574 1/20 0.42
HTT P42858 1/20 0.42
LMNA P02545 3/20 0.41
FFAR4 Q5NUL3 1/20 0.41
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL702409 0.83 GAA (0.58) GAAKMT2AMEN1SMN1; SMN2POLB
SCHEMBL20245217 0.83 TDP1 (0.47) GAAKMT2AMEN1SMN1; SMN2HCRTR2
SCHEMBL600069 0.79 GAA (0.58) GAATDP1LMNAHDAC3HDAC4
SCHEMBL5127182 0.78 GAA (0.66) GAAKMT2ASMN1; SMN2POLBHTT
SCHEMBL31532603 0.76 HSD11B1 (0.47) GAAKMT2AHCRTR2PTGDRPTGDR2
SCHEMBL5183679 0.75 NPSR1 (0.51) GAAKMT2AMEN1SMN1; SMN2HTT
SCHEMBL16720055 0.72 HTR2A (0.55) KMT2AMEN1SMN1; SMN2POLBHCRTR2
SCHEMBL5124229 0.72 GAA (0.48) GAAHTT
SCHEMBL16894187 0.72 HCRTR2 (0.47) KMT2AMEN1HCRTR2HTR2AHTR2C
SCHEMBL599787 0.70 GAA (0.59) GAAKMT2AMEN1SMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8318769-B2 Substituted sulfonamide compounds GRUENETHAL GMBH (DE) 2012-11-27 US disclosed
US-8124624-B2 Substituted sulfonamide compounds GRUENENTHAL GMBH (DE) 2012-02-28 US disclosed
US-20090264400-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2009-10-22 US disclosed
US-20090264407-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090264407-A1 Substituted Sulfonamide Compounds CNR1, SUCNR1, OPRL1 GAA 2480/4885KMT2A 3631/4885MEN1 3536/4885
US-20090264400-A1 Substituted Sulfonamide Compounds BDKRB1, BDKRB2, TRPV1 GAA 2852/4885KMT2A 2533/4885MEN1 2417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.